ORASCOVERY Trademark

Trademark Overview

On Wednesday, July 15, 2020, a trademark application was filed for ORASCOVERY with the United States Patent and Trademark Office. The USPTO has given the ORASCOVERY trademark a serial number of 90053396. The federal status of this trademark filing is REGISTERED as of Tuesday, March 7, 2023. This trademark is owned by Athenex, Inc.. The ORASCOVERY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing information via a global computer network on the research and development of drugs for the treatment of cancer which involves the use of a pharmaceutical drug platform that facilitates the absorption of anti-cancer drugs; providing information relating to research and development of drugs for the treatment of cancer
orascovery

General Information

Serial Number90053396
Word MarkORASCOVERY
Filing DateWednesday, July 15, 2020
Status700 - REGISTERED
Status DateTuesday, March 7, 2023
Registration Number6994088
Registration DateTuesday, March 7, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 4, 2021

Trademark Statements

Goods and ServicesProviding information via a global computer network on the research and development of drugs for the treatment of cancer which involves the use of a pharmaceutical drug platform that facilitates the absorption of anti-cancer drugs; providing information relating to research and development of drugs for the treatment of cancer

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 12, 2020
Primary Code042
First Use Anywhere DateMonday, June 5, 2017
First Use In Commerce DateMonday, June 5, 2017

Trademark Owner History

Party NameAthenex, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBuffalo, NY 14203
Party NameAthenex, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBuffalo, NY 14203
Party NameAthenex, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBuffalo, NY 14203

Trademark Events

Event DateEvent Description
Tuesday, March 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 7, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, January 31, 20231(B) BASIS DELETED; PROCEED TO REGISTRATION
Thursday, December 15, 2022NOTICE OF ALLOWANCE CANCELLED
Tuesday, January 31, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 15, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, June 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 31, 2022SOU EXTENSION 2 GRANTED
Tuesday, May 31, 2022SOU EXTENSION 2 FILED
Tuesday, May 31, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 13, 2021SOU EXTENSION 1 GRANTED
Monday, December 13, 2021SOU EXTENSION 1 FILED
Monday, December 13, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 29, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 4, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 4, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 14, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 24, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, March 24, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 24, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, March 24, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 9, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, March 9, 2021FINAL REFUSAL E-MAILED
Tuesday, March 9, 2021FINAL REFUSAL WRITTEN
Friday, February 19, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 18, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 18, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, November 1, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, November 1, 2020NON-FINAL ACTION E-MAILED
Sunday, November 1, 2020NON-FINAL ACTION WRITTEN
Monday, October 26, 2020ASSIGNED TO EXAMINER
Wednesday, August 12, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 18, 2020NEW APPLICATION ENTERED

Related Keywords

orascovery drugs cancer treatment providing development information research facilitates platform absorption